Summary
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature, and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
According to APO Research, The global Phage Therapy market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Phage Therapy is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Phage Therapy is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Phage Therapy is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Phage Therapy is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Phage Therapy include NPO Microgen, Proteon Pharmaceuticals, Phagelux, Intralytix, Micreos, Eliava BioPreparations, Locus Biosciences,Inc, Pharmex Group,LLC and Pherecydes Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Phage Therapy, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Phage Therapy, also provides the revenue of main regions and countries. Of the upcoming market potential for Phage Therapy, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Phage Therapy revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Phage Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Phage Therapy revenue, projected growth trends, production technology, application and end-user industry.
Phage Therapy segment by Company
NPO Microgen
Proteon Pharmaceuticals
Phagelux
Intralytix
Micreos
Eliava BioPreparations
Locus Biosciences,Inc
Pharmex Group,LLC
Pherecydes Pharma
APS Biocontrol Ltd. (APS)
Qingdao Phagepharm Bio-tech
Fixed-Phage Limited
Zeptometrix
Phage International, Inc.
MicroMir
iNtODEWORLD, Inc.
NEXTBIOTICS
Armata Pharmaceuticals, Inc.
Innophage
Adaptive Phage Therapeutics
TechnoPhage
Phage Therapy segment by Type
DsDNA Bacteriophage
SsDNA Bacteriophage
SsRNA Bacteriophage
Others
Phage Therapy segment by Application
Animal Health
Aquaculture
Agriculture
Food Industry
Human Health
Others
Phage Therapy segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Phage Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Phage Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Phage Therapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Phage Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Phage Therapy company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Phage Therapy revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
1 Market Overview
1.1 Product Definition
1.2 Phage Therapy Market by Type
1.2.1 Global Phage Therapy Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 DsDNA Bacteriophage
1.2.3 SsDNA Bacteriophage
1.2.4 SsRNA Bacteriophage
1.2.5 Others
1.3 Phage Therapy Market by Application
1.3.1 Global Phage Therapy Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Animal Health
1.3.3 Aquaculture
1.3.4 Agriculture
1.3.5 Food Industry
1.3.6 Human Health
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Phage Therapy Market Dynamics
2.1 Phage Therapy Industry Trends
2.2 Phage Therapy Industry Drivers
2.3 Phage Therapy Industry Opportunities and Challenges
2.4 Phage Therapy Industry Restraints
3 Global Growth Perspective
3.1 Global Phage Therapy Market Perspective (2019-2030)
3.2 Global Phage Therapy Growth Trends by Region
3.2.1 Global Phage Therapy Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global Phage Therapy Market Size by Region (2019-2024)
3.2.3 Global Phage Therapy Market Size by Region (2025-2030)
4 Competitive Landscape by Players
4.1 Global Phage Therapy Revenue by Players
4.1.1 Global Phage Therapy Revenue by Players (2019-2024)
4.1.2 Global Phage Therapy Revenue Market Share by Players (2019-2024)
4.1.3 Global Phage Therapy Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global Phage Therapy Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global Phage Therapy Key Players Headquarters & Area Served
4.4 Global Phage Therapy Players, Product Type & Application
4.5 Global Phage Therapy Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global Phage Therapy Market CR5 and HHI
4.6.2 Global Top 5 and 10 Phage Therapy Players Market Share by Revenue in 2023
4.6.3 2023 Phage Therapy Tier 1, Tier 2, and Tier 3
5 Phage Therapy Market Size by Type
5.1 Global Phage Therapy Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global Phage Therapy Revenue by Type (2019-2030)
5.3 Global Phage Therapy Revenue Market Share by Type (2019-2030)
6 Phage Therapy Market Size by Application
6.1 Global Phage Therapy Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global Phage Therapy Revenue by Application (2019-2030)
6.3 Global Phage Therapy Revenue Market Share by Application (2019-2030)
7 Company Profiles
7.1 NPO Microgen
7.1.1 NPO Microgen Comapny Information
7.1.2 NPO Microgen Business Overview
7.1.3 NPO Microgen Phage Therapy Revenue and Gross Margin (2019-2024)
7.1.4 NPO Microgen Phage Therapy Product Portfolio
7.1.5 NPO Microgen Recent Developments
7.2 Proteon Pharmaceuticals
7.2.1 Proteon Pharmaceuticals Comapny Information
7.2.2 Proteon Pharmaceuticals Business Overview
7.2.3 Proteon Pharmaceuticals Phage Therapy Revenue and Gross Margin (2019-2024)
7.2.4 Proteon Pharmaceuticals Phage Therapy Product Portfolio
7.2.5 Proteon Pharmaceuticals Recent Developments
7.3 Phagelux
7.3.1 Phagelux Comapny Information
7.3.2 Phagelux Business Overview
7.3.3 Phagelux Phage Therapy Revenue and Gross Margin (2019-2024)
7.3.4 Phagelux Phage Therapy Product Portfolio
7.3.5 Phagelux Recent Developments
7.4 Intralytix
7.4.1 Intralytix Comapny Information
7.4.2 Intralytix Business Overview
7.4.3 Intralytix Phage Therapy Revenue and Gross Margin (2019-2024)
7.4.4 Intralytix Phage Therapy Product Portfolio
7.4.5 Intralytix Recent Developments
7.5 Micreos
7.5.1 Micreos Comapny Information
7.5.2 Micreos Business Overview
7.5.3 Micreos Phage Therapy Revenue and Gross Margin (2019-2024)
7.5.4 Micreos Phage Therapy Product Portfolio
7.5.5 Micreos Recent Developments
7.6 Eliava BioPreparations
7.6.1 Eliava BioPreparations Comapny Information
7.6.2 Eliava BioPreparations Business Overview
7.6.3 Eliava BioPreparations Phage Therapy Revenue and Gross Margin (2019-2024)
7.6.4 Eliava BioPreparations Phage Therapy Product Portfolio
7.6.5 Eliava BioPreparations Recent Developments
7.7 Locus Biosciences,Inc
7.7.1 Locus Biosciences,Inc Comapny Information
7.7.2 Locus Biosciences,Inc Business Overview
7.7.3 Locus Biosciences,Inc Phage Therapy Revenue and Gross Margin (2019-2024)
7.7.4 Locus Biosciences,Inc Phage Therapy Product Portfolio
7.7.5 Locus Biosciences,Inc Recent Developments
7.8 Pharmex Group,LLC
7.8.1 Pharmex Group,LLC Comapny Information
7.8.2 Pharmex Group,LLC Business Overview
7.8.3 Pharmex Group,LLC Phage Therapy Revenue and Gross Margin (2019-2024)
7.8.4 Pharmex Group,LLC Phage Therapy Product Portfolio
7.8.5 Pharmex Group,LLC Recent Developments
7.9 Pherecydes Pharma
7.9.1 Pherecydes Pharma Comapny Information
7.9.2 Pherecydes Pharma Business Overview
7.9.3 Pherecydes Pharma Phage Therapy Revenue and Gross Margin (2019-2024)
7.9.4 Pherecydes Pharma Phage Therapy Product Portfolio
7.9.5 Pherecydes Pharma Recent Developments
7.10 APS Biocontrol Ltd. (APS)
7.10.1 APS Biocontrol Ltd. (APS) Comapny Information
7.10.2 APS Biocontrol Ltd. (APS) Business Overview
7.10.3 APS Biocontrol Ltd. (APS) Phage Therapy Revenue and Gross Margin (2019-2024)
7.10.4 APS Biocontrol Ltd. (APS) Phage Therapy Product Portfolio
7.10.5 APS Biocontrol Ltd. (APS) Recent Developments
7.11 Qingdao Phagepharm Bio-tech
7.11.1 Qingdao Phagepharm Bio-tech Comapny Information
7.11.2 Qingdao Phagepharm Bio-tech Business Overview
7.11.3 Qingdao Phagepharm Bio-tech Phage Therapy Revenue and Gross Margin (2019-2024)
7.11.4 Qingdao Phagepharm Bio-tech Phage Therapy Product Portfolio
7.11.5 Qingdao Phagepharm Bio-tech Recent Developments
7.12 Fixed-Phage Limited
7.12.1 Fixed-Phage Limited Comapny Information
7.12.2 Fixed-Phage Limited Business Overview
7.12.3 Fixed-Phage Limited Phage Therapy Revenue and Gross Margin (2019-2024)
7.12.4 Fixed-Phage Limited Phage Therapy Product Portfolio
7.12.5 Fixed-Phage Limited Recent Developments
7.13 Zeptometrix
7.13.1 Zeptometrix Comapny Information
7.13.2 Zeptometrix Business Overview
7.13.3 Zeptometrix Phage Therapy Revenue and Gross Margin (2019-2024)
7.13.4 Zeptometrix Phage Therapy Product Portfolio
7.13.5 Zeptometrix Recent Developments
7.14 Phage International, Inc.
7.14.1 Phage International, Inc. Comapny Information
7.14.2 Phage International, Inc. Business Overview
7.14.3 Phage International, Inc. Phage Therapy Revenue and Gross Margin (2019-2024)
7.14.4 Phage International, Inc. Phage Therapy Product Portfolio
7.14.5 Phage International, Inc. Recent Developments
7.15 MicroMir
7.15.1 MicroMir Comapny Information
7.15.2 MicroMir Business Overview
7.15.3 MicroMir Phage Therapy Revenue and Gross Margin (2019-2024)
7.15.4 MicroMir Phage Therapy Product Portfolio
7.15.5 MicroMir Recent Developments
7.16 iNtODEWORLD, Inc.
7.16.1 iNtODEWORLD, Inc. Comapny Information
7.16.2 iNtODEWORLD, Inc. Business Overview
7.16.3 iNtODEWORLD, Inc. Phage Therapy Revenue and Gross Margin (2019-2024)
7.16.4 iNtODEWORLD, Inc. Phage Therapy Product Portfolio
7.16.5 iNtODEWORLD, Inc. Recent Developments
7.17 NEXTBIOTICS
7.17.1 NEXTBIOTICS Comapny Information
7.17.2 NEXTBIOTICS Business Overview
7.17.3 NEXTBIOTICS Phage Therapy Revenue and Gross Margin (2019-2024)
7.17.4 NEXTBIOTICS Phage Therapy Product Portfolio
7.17.5 NEXTBIOTICS Recent Developments
7.18 Armata Pharmaceuticals, Inc.
7.18.1 Armata Pharmaceuticals, Inc. Comapny Information
7.18.2 Armata Pharmaceuticals, Inc. Business Overview
7.18.3 Armata Pharmaceuticals, Inc. Phage Therapy Revenue and Gross Margin (2019-2024)
7.18.4 Armata Pharmaceuticals, Inc. Phage Therapy Product Portfolio
7.18.5 Armata Pharmaceuticals, Inc. Recent Developments
7.19 Innophage
7.19.1 Innophage Comapny Information
7.19.2 Innophage Business Overview
7.19.3 Innophage Phage Therapy Revenue and Gross Margin (2019-2024)
7.19.4 Innophage Phage Therapy Product Portfolio
7.19.5 Innophage Recent Developments
7.20 Adaptive Phage Therapeutics
7.20.1 Adaptive Phage Therapeutics Comapny Information
7.20.2 Adaptive Phage Therapeutics Business Overview
7.20.3 Adaptive Phage Therapeutics Phage Therapy Revenue and Gross Margin (2019-2024)
7.20.4 Adaptive Phage Therapeutics Phage Therapy Product Portfolio
7.20.5 Adaptive Phage Therapeutics Recent Developments
7.21 TechnoPhage
7.21.1 TechnoPhage Comapny Information
7.21.2 TechnoPhage Business Overview
7.21.3 TechnoPhage Phage Therapy Revenue and Gross Margin (2019-2024)
7.21.4 TechnoPhage Phage Therapy Product Portfolio
7.21.5 TechnoPhage Recent Developments
8 North America
8.1 North America Phage Therapy Revenue (2019-2030)
8.2 North America Phage Therapy Revenue by Type (2019-2030)
8.2.1 North America Phage Therapy Revenue by Type (2019-2024)
8.2.2 North America Phage Therapy Revenue by Type (2025-2030)
8.3 North America Phage Therapy Revenue Share by Type (2019-2030)
8.4 North America Phage Therapy Revenue by Application (2019-2030)
8.4.1 North America Phage Therapy Revenue by Application (2019-2024)
8.4.2 North America Phage Therapy Revenue by Application (2025-2030)
8.5 North America Phage Therapy Revenue Share by Application (2019-2030)
8.6 North America Phage Therapy Revenue by Country
8.6.1 North America Phage Therapy Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America Phage Therapy Revenue by Country (2019-2024)
8.6.3 North America Phage Therapy Revenue by Country (2025-2030)
8.6.4 United States
8.6.5 Canada
9 Europe
9.1 Europe Phage Therapy Revenue (2019-2030)
9.2 Europe Phage Therapy Revenue by Type (2019-2030)
9.2.1 Europe Phage Therapy Revenue by Type (2019-2024)
9.2.2 Europe Phage Therapy Revenue by Type (2025-2030)
9.3 Europe Phage Therapy Revenue Share by Type (2019-2030)
9.4 Europe Phage Therapy Revenue by Application (2019-2030)
9.4.1 Europe Phage Therapy Revenue by Application (2019-2024)
9.4.2 Europe Phage Therapy Revenue by Application (2025-2030)
9.5 Europe Phage Therapy Revenue Share by Application (2019-2030)
9.6 Europe Phage Therapy Revenue by Country
9.6.1 Europe Phage Therapy Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe Phage Therapy Revenue by Country (2019-2024)
9.6.3 Europe Phage Therapy Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
10 China
10.1 China Phage Therapy Revenue (2019-2030)
10.2 China Phage Therapy Revenue by Type (2019-2030)
10.2.1 China Phage Therapy Revenue by Type (2019-2024)
10.2.2 China Phage Therapy Revenue by Type (2025-2030)
10.3 China Phage Therapy Revenue Share by Type (2019-2030)
10.4 China Phage Therapy Revenue by Application (2019-2030)
10.4.1 China Phage Therapy Revenue by Application (2019-2024)
10.4.2 China Phage Therapy Revenue by Application (2025-2030)
10.5 China Phage Therapy Revenue Share by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Phage Therapy Revenue (2019-2030)
11.2 Asia Phage Therapy Revenue by Type (2019-2030)
11.2.1 Asia Phage Therapy Revenue by Type (2019-2024)
11.2.2 Asia Phage Therapy Revenue by Type (2025-2030)
11.3 Asia Phage Therapy Revenue Share by Type (2019-2030)
11.4 Asia Phage Therapy Revenue by Application (2019-2030)
11.4.1 Asia Phage Therapy Revenue by Application (2019-2024)
11.4.2 Asia Phage Therapy Revenue by Application (2025-2030)
11.5 Asia Phage Therapy Revenue Share by Application (2019-2030)
11.6 Asia Phage Therapy Revenue by Country
11.6.1 Asia Phage Therapy Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia Phage Therapy Revenue by Country (2019-2024)
11.6.3 Asia Phage Therapy Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 Middle East, Africa, Latin America
12.1 MEALA Phage Therapy Revenue (2019-2030)
12.2 MEALA Phage Therapy Revenue by Type (2019-2030)
12.2.1 MEALA Phage Therapy Revenue by Type (2019-2024)
12.2.2 MEALA Phage Therapy Revenue by Type (2025-2030)
12.3 MEALA Phage Therapy Revenue Share by Type (2019-2030)
12.4 MEALA Phage Therapy Revenue by Application (2019-2030)
12.4.1 MEALA Phage Therapy Revenue by Application (2019-2024)
12.4.2 MEALA Phage Therapy Revenue by Application (2025-2030)
12.5 MEALA Phage Therapy Revenue Share by Application (2019-2030)
12.6 MEALA Phage Therapy Revenue by Country
12.6.1 MEALA Phage Therapy Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA Phage Therapy Revenue by Country (2019-2024)
12.6.3 MEALA Phage Therapy Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
List of Tables
Table 1. Global Phage Therapy Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 1. DsDNA Bacteriophage Major Manufacturers
Table 2. SsDNA Bacteriophage Major Manufacturers
Table 3. SsRNA Bacteriophage Major Manufacturers
Table 4. Others Major Manufacturers
Table 5. Global Phage Therapy Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 6. Animal Health Major Manufacturers
Table 7. Aquaculture Major Manufacturers
Table 8. Agriculture Major Manufacturers
Table 9. Food Industry Major Manufacturers
Table 10. Human Health Major Manufacturers
Table 11. Others Major Manufacturers
Table 12. Phage Therapy Industry Trends
Table 13. Phage Therapy Industry Drivers
Table 14. Phage Therapy Industry Opportunities and Challenges
Table 15. Phage Therapy Industry Restraints
Table 16. Global Phage Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Phage Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 18. Global Phage Therapy Market Share by Region (2019-2024)
Table 19. Global Phage Therapy Market Size by Region (2025-2030) & (US$ Million)
Table 20. Global Phage Therapy Market Share by Region (2025-2030)
Table 21. Global Phage Therapy Revenue by Players (US$ Million) & (2019-2024)
Table 22. Global Phage Therapy Revenue Market Share by Players (2019-2024)
Table 23. Global Phage Therapy Key Players Ranking, 2022 VS 2023 VS 2024
Table 24. Global Phage Therapy Key Players Headquarters & Area Served
Table 25. Global Phage Therapy Players, Product Type & Application
Table 26. Global Phage Therapy Players Commercialization Time
Table 27. Global Players Market Concentration Ratio (CR5 and HHI)
Table 28. Global Phage Therapy by Players Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 29. Global Phage Therapy Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 30. Global Phage Therapy Revenue by Type (2019-2024) & (US$ Million)
Table 31. Global Phage Therapy Revenue by Type (2025-2030) & (US$ Million)
Table 32. Global Phage Therapy Revenue Market Share by Type (2019-2024) & (US$ Million)
Table 33. Global Phage Therapy Revenue Market Share by Type (2025-2030) & (US$ Million)
Table 34. Global Phage Therapy Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 35. Global Phage Therapy Revenue by Application (2019-2024) & (US$ Million)
Table 36. Global Phage Therapy Revenue by Application (2025-2030) & (US$ Million)
Table 37. Global Phage Therapy Revenue Market Share by Application (2019-2024) & (US$ Million)
Table 38. Global Phage Therapy Revenue Market Share by Application (2025-2030) & (US$ Million)
Table 39. NPO Microgen Company Information
Table 40. NPO Microgen Business Overview
Table 41. NPO Microgen Phage Therapy Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 42. NPO Microgen Phage Therapy Product Portfolio
Table 43. NPO Microgen Recent Development
Table 44. Proteon Pharmaceuticals Company Information
Table 45. Proteon Pharmaceuticals Business Overview
Table 46. Proteon Pharmaceuticals Phage Therapy Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 47. Proteon Pharmaceuticals Phage Therapy Product Portfolio
Table 48. Proteon Pharmaceuticals Recent Development
Table 49. Phagelux Company Information
Table 50. Phagelux Business Overview
Table 51. Phagelux Phage Therapy Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 52. Phagelux Phage Therapy Product Portfolio
Table 53. Phagelux Recent Development
Table 54. Intralytix Company Information
Table 55. Intralytix Business Overview
Table 56. Intralytix Phage Therapy Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 57. Intralytix Phage Therapy Product Portfolio
Table 58. Intralytix Recent Development
Table 59. Micreos Company Information
Table 60. Micreos Business Overview
Table 61. Micreos Phage Therapy Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 62. Micreos Phage Therapy Product Portfolio
Table 63. Micreos Recent Development
Table 64. Eliava BioPreparations Company Information
Table 65. Eliava BioPreparations Business Overview
Table 66. Eliava BioPreparations Phage Therapy Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 67. Eliava BioPreparations Phage Therapy Product Portfolio
Table 68. Eliava BioPreparations Recent Development
Table 69. Locus Biosciences,Inc Company Information
Table 70. Locus Biosciences,Inc Business Overview
Table 71. Locus Biosciences,Inc Phage Therapy Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 72. Locus Biosciences,Inc Phage Therapy Product Portfolio
Table 73. Locus Biosciences,Inc Recent Development
Table 74. Pharmex Group,LLC Company Information
Table 75. Pharmex Group,LLC Business Overview
Table 76. Pharmex Group,LLC Phage Therapy Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 77. Pharmex Group,LLC Phage Therapy Product Portfolio
Table 78. Pharmex Group,LLC Recent Development
Table 79. Pherecydes Pharma Company Information
Table 80. Pherecydes Pharma Business Overview
Table 81. Pherecydes Pharma Phage Therapy Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 82. Pherecydes Pharma Phage Therapy Product Portfolio
Table 83. Pherecydes Pharma Recent Development
Table 84. APS Biocontrol Ltd. (APS) Company Information
Table 85. APS Biocontrol Ltd. (APS) Business Overview
Table 86. APS Biocontrol Ltd. (APS) Phage Therapy Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 87. APS Biocontrol Ltd. (APS) Phage Therapy Product Portfolio
Table 88. APS Biocontrol Ltd. (APS) Recent Development
Table 89. Qingdao Phagepharm Bio-tech Company Information
Table 90. Qingdao Phagepharm Bio-tech Business Overview
Table 91. Qingdao Phagepharm Bio-tech Phage Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 92. Qingdao Phagepharm Bio-tech Phage Therapy Product Portfolio
Table 93. Qingdao Phagepharm Bio-tech Recent Development
Table 94. Fixed-Phage Limited Company Information
Table 95. Fixed-Phage Limited Business Overview
Table 96. Fixed-Phage Limited Phage Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 97. Fixed-Phage Limited Phage Therapy Product Portfolio
Table 98. Fixed-Phage Limited Recent Development
Table 99. Zeptometrix Company Information
Table 100. Zeptometrix Business Overview
Table 101. Zeptometrix Phage Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 102. Zeptometrix Phage Therapy Product Portfolio
Table 103. Zeptometrix Recent Development
Table 104. Phage International, Inc. Company Information
Table 105. Phage International, Inc. Business Overview
Table 106. Phage International, Inc. Phage Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 107. Phage International, Inc. Phage Therapy Product Portfolio
Table 108. Phage International, Inc. Recent Development
Table 109. MicroMir Company Information
Table 110. MicroMir Business Overview
Table 111. MicroMir Phage Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 112. MicroMir Phage Therapy Product Portfolio
Table 113. MicroMir Recent Development
Table 114. iNtODEWORLD, Inc. Company Information
Table 115. iNtODEWORLD, Inc. Business Overview
Table 116. iNtODEWORLD, Inc. Phage Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 117. iNtODEWORLD, Inc. Phage Therapy Product Portfolio
Table 118. iNtODEWORLD, Inc. Recent Development
Table 119. NEXTBIOTICS Company Information
Table 120. NEXTBIOTICS Business Overview
Table 121. NEXTBIOTICS Phage Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 122. NEXTBIOTICS Phage Therapy Product Portfolio
Table 123. NEXTBIOTICS Recent Development
Table 124. Armata Pharmaceuticals, Inc. Company Information
Table 125. Armata Pharmaceuticals, Inc. Business Overview
Table 126. Armata Pharmaceuticals, Inc. Phage Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 127. Armata Pharmaceuticals, Inc. Phage Therapy Product Portfolio
Table 128. Armata Pharmaceuticals, Inc. Recent Development
Table 129. Innophage Company Information
Table 130. Innophage Business Overview
Table 131. Innophage Phage Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 132. Innophage Phage Therapy Product Portfolio
Table 133. Innophage Recent Development
Table 134. Adaptive Phage Therapeutics Company Information
Table 135. Adaptive Phage Therapeutics Business Overview
Table 136. Adaptive Phage Therapeutics Phage Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 137. Adaptive Phage Therapeutics Phage Therapy Product Portfolio
Table 138. Adaptive Phage Therapeutics Recent Development
Table 139. TechnoPhage Company Information
Table 140. TechnoPhage Business Overview
Table 141. TechnoPhage Phage Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 142. TechnoPhage Phage Therapy Product Portfolio
Table 143. TechnoPhage Recent Development
Table 144. North America Phage Therapy Revenue by Type (2019-2024) & (US$ Million)
Table 145. North America Phage Therapy Revenue by Application (2019-2024) & (US$ Million)
Table 146. North America Phage Therapy Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 147. North America Phage Therapy Revenue by Country (2019-2024) & (US$ Million)
Table 148. North America Phage Therapy Revenue by Country (2025-2030) & (US$ Million)
Table 149. Europe Phage Therapy Revenue by Type (2019-2024) & (US$ Million)
Table 150. Europe Phage Therapy Revenue by Application (2019-2024) & (US$ Million)
Table 151. Europe Phage Therapy Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 152. Europe Phage Therapy Revenue by Country (2019-2024) & (US$ Million)
Table 153. Europe Phage Therapy Revenue by Country (2025-2030) & (US$ Million)
Table 154. China Phage Therapy Revenue by Type (2019-2024) & (US$ Million)
Table 155. China Phage Therapy Revenue by Application (2019-2024) & (US$ Million)
Table 156. Asia Phage Therapy Revenue by Type (2019-2024) & (US$ Million)
Table 157. Asia Phage Therapy Revenue by Application (2019-2024) & (US$ Million)
Table 158. Asia Phage Therapy Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 159. Asia Phage Therapy Revenue by Country (2019-2024) & (US$ Million)
Table 160. Asia Phage Therapy Revenue by Country (2025-2030) & (US$ Million)
Table 161. MEALA Phage Therapy Revenue by Type (2019-2024) & (US$ Million)
Table 162. MEALA Phage Therapy Revenue by Application (2019-2024) & (US$ Million)
Table 163. MEALA Phage Therapy Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 164. MEALA Phage Therapy Revenue by Country (2019-2024) & (US$ Million)
Table 165. MEALA Phage Therapy Revenue by Country (2025-2030) & (US$ Million)
Table 166. Research Programs/Design for This Report
Table 167. Authors List of This Report
Table 168. Secondary Sources
Table 169. Primary Sources
List of Figures
Figure 1. Phage Therapy Product Picture
Figure 2. Global Phage Therapy Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Phage Therapy Market Size Share 2019 VS 2023 VS 2030
Figure 4. DsDNA Bacteriophage Picture
Figure 5. SsDNA Bacteriophage Picture
Figure 6. SsRNA Bacteriophage Picture
Figure 7. Others Picture
Figure 8. Global Phage Therapy Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 9. Global Phage Therapy Market Size Share 2019 VS 2023 VS 2030
Figure 10. Animal Health Picture
Figure 11. Aquaculture Picture
Figure 12. Agriculture Picture
Figure 13. Food Industry Picture
Figure 14. Human Health Picture
Figure 15. Others Picture
Figure 16. Global Phage Therapy Market Size (US$ Million) & (2019-2030)
Figure 17. Global Phage Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Phage Therapy Market Share by Region: 2019 VS 2023 VS 2030
Figure 19. Global Phage Therapy Players Revenue Share Top 10 and Top 5 in 2023
Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 21. Global Phage Therapy Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Phage Therapy Revenue Market Share 2019 VS 2023 VS 2030
Figure 23. Global Phage Therapy Revenue Market Share by Type (2019-2030)
Figure 24. Global Phage Therapy Revenue by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 25. Global Phage Therapy Revenue Market Share by Application (2019 VS 2023 VS 2030)
Figure 26. Global Phage Therapy Revenue Market Share by Application (2019-2030)
Figure 27. North America Phage Therapy Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 28. North America Phage Therapy Revenue by Type (2025-2030) & (US$ Million)
Figure 29. North America Phage Therapy Revenue Share by Type (2019-2030)
Figure 30. North America Phage Therapy Revenue by Application (2025-2030) & (US$ Million)
Figure 31. North America Phage Therapy Revenue Share by Application (2019-2030)
Figure 32. North America Phage Therapy Revenue Share by Country (2019-2030)
Figure 33. United States Phage Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 34. Canada Phage Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 35. Europe Phage Therapy Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 36. Europe Phage Therapy Revenue by Type (2025-2030) & (US$ Million)
Figure 37. Europe Phage Therapy Revenue Share by Type (2019-2030)
Figure 38. Europe Phage Therapy Revenue by Application (2025-2030) & (US$ Million)
Figure 39. Europe Phage Therapy Revenue Share by Application (2019-2030)
Figure 40. Europe Phage Therapy Revenue Share by Country (2019-2030)
Figure 41. Germany Phage Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 42. France Phage Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 43. U.K. Phage Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 44. Italy Phage Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 45. Russia Phage Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 46. Nordic Countries Phage Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 47. China Phage Therapy Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 48. China Phage Therapy Revenue by Type (2025-2030) & (US$ Million)
Figure 49. China Phage Therapy Revenue Share by Type (2019-2030)
Figure 50. China Phage Therapy Revenue by Application (2025-2030) & (US$ Million)
Figure 51. China Phage Therapy Revenue Share by Application (2019-2030)
Figure 52. Asia Phage Therapy Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 53. Asia Phage Therapy Revenue by Type (2025-2030) & (US$ Million)
Figure 54. Asia Phage Therapy Revenue Share by Type (2019-2030)
Figure 55. Asia Phage Therapy Revenue by Application (2025-2030) & (US$ Million)
Figure 56. Asia Phage Therapy Revenue Share by Application (2019-2030)
Figure 57. Asia Phage Therapy Revenue Share by Country (2019-2030)
Figure 58. Japan Phage Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 59. South Korea Phage Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 60. India Phage Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 61. Australia Phage Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 62. China Taiwan Phage Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 63. Southeast Asia Phage Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 64. MEALA Phage Therapy Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 65. MEALA Phage Therapy Revenue by Type (2025-2030) & (US$ Million)
Figure 66. MEALA Phage Therapy Revenue Share by Type (2019-2030)
Figure 67. MEALA Phage Therapy Revenue by Application (2025-2030) & (US$ Million)
Figure 68. MEALA Phage Therapy Revenue Share by Application (2019-2030)
Figure 69. MEALA Phage Therapy Revenue Share by Country (2019-2030)
Figure 70. Mexico Phage Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 71. South Korea Phage Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 72. Brazil Phage Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 73. Israel Phage Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 74. Argentina Phage Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 75. Colombia Phage Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 76. Turkey Phage Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 77. Saudi Arabia Phage Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 78. UAE Phage Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 79. Years Considered
Figure 80. Research Process
Figure 81. Key Executives Interviewed
